15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Edesa Biotech Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $5.00 to $5.00, so the covering firms are broadly aligned. The average target of $5.00 is roughly in line with the current $5.00. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.43 next quarter toward $-2.01 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Edesa Biotech Inc.
As of Jul, 1 of 1 firms rate EDSA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
EDSA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.43
Range $-0.47 – $-0.40 · 2 analysts · +36% YoY
Next period, 2 analysts expect Edesa Biotech Inc to earn $-0.43 a share (range $-0.47 – $-0.40), versus $-0.32 a year earlier. Full-year consensus is $-1.66, growing to $-2.01 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Edesa Biotech Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EDSA.
#1
Yi Chen
HC Wainwright & Co. · Rank #238
Buy
$5.00+0.1% to target
Overall win rate
34%
+ Follow
#2
Vernon Bernardino
HC Wainwright & Co. · Rank #379
Buy
$21.00+320.4% to target
Overall win rate
14%
+ Follow
#3
DP
Dev Prasad
Lucid Capital
Buy
$9.00+80.2% to target
Coverage
—
+ Follow
EDSA stock forecast FAQ
What is EDSA's average 12-month price target?+
The 1 analysts with a live target average $5.00 for Edesa Biotech Inc over the next 12 months, ranging from a $5.00 high to a $5.00 low.
Is EDSA stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover EDSA?+
1 analysts have an active rating on Edesa Biotech Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering EDSA?+
Among analysts who currently cover EDSA, Yi Chen of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #238). Their current call is Buy with a $5.00 target.
What is Edesa Biotech Inc's projected EPS for next quarter?+
The consensus estimate is $-0.43 per share (range $-0.47 – $-0.40) across 2 analysts. Full-year EPS is projected at $-1.66, rising to $-2.01 the following year.
How much revenue is Edesa Biotech Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading EDSA lately?+
As of Jul, 1 of 1 firms rate EDSA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EDSA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
